moneyheap
IEX · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is IDEX Corporation (IEX) stock moving?
IDEX reported record Q3 2026 results on Oct 28: sales of $952M (+8%), adjusted EPS of $2.33 (+15%, above the $2.23 estimate), and orders of $991M (+13%). Management raised FY2026 adjusted EPS guidance to $8.91-$8.96 from $8.70-$8.85 and organic sales growth to 6.5%-6.8%. Analysts followed with Buy or Outperform ratings and higher or maintained targets ranging from $256 (BMO) to $283 (RBC), averaging about $272. The shares closed at $239.33 on Oct 29 but then fell about 7% to $222.60 by Nov 5 on heavy volume, with no company-specific news in the feed explaining the drop. They recovered to $236.90 on Nov 10, still roughly 13% below the average target. Volume spiked on the earnings day (about 1.64M shares) and was light on Nov 10 (about 397K). The Indian Energy Exchange items in the feed share the IEX ticker but concern a different company, so they were excluded. The main risks are the post-earnings sell-off, the need for continued margin gains amid inflation, and a news flow that is now mostly stale.
News behind the analysis
- IDEX Corporation Reports Record Third Quarter 2026 Financial ResultsIDEX reported record Q3 sales and adjusted EPS, with nearly $1 billion in new orders. The company raised full-year guidance.
- IDEX Raises FY2026 Adj EPS Guidance from $8.70-$8.85 to $8.91-$8.96 vs $8.81 EstFull-year adjusted EPS guidance was raised to $8.91-$8.96, about 12% growth at the midpoint, above the $8.81 consensus estimate. Organic sales growth guidance also rose to 6.5%-6.8%.
- IDEX Q3 Adj. EPS $2.33 Beats $2.23 Estimate, Sales $951.700M Beat $930.753M EstimateAdjusted EPS of $2.33 beat the $2.23 estimate, and sales of $951.7M beat the $930.8M estimate.
- Oppenheimer Maintains Outperform on IDEX, Raises Price Target to $280Oppenheimer kept its Outperform rating and raised its price target to $280 after the Q3 report.
- Citigroup Maintains Buy on IDEX, Raises Price Target to $272Citigroup kept its Buy rating and raised its price target to $272.
- Stifel Maintains Buy on IDEX, Raises Price Target to $273Stifel kept its Buy rating and raised its price target to $273.
- RBC Capital Maintains Outperform on IDEX, Lowers Price Target to $283RBC kept its Outperform rating and trimmed its price target to $283 from $285.
- BMO Capital Adjusts Price Target on IDEX CorporationBMO Capital Markets raised its price target to $256 from $251 following the Q3 2026 earnings release.
- Seaport Global Securities Adjusts IDEX Price Target to $270 From $250Seaport Global Securities raised its price target for IDEX from $250 to $270.
About IDEX Corporation
IDEX Corporation is an industrial company based in Northbrook, Illinois. It makes highly engineered parts like pumps, flow meters, precision optics, fluidics components and fire and rescue equipment. Its products sell into many small niche markets, and it grows partly by buying specialized businesses and running them with an "80/20" focus on its most profitable products and customers.
How it makes money
IDEX makes money by selling engineered products and components through three segments. Health & Science Technologies is the largest and fastest-growing: it sells optics, fluidics, sealing and precision parts used in life sciences, semiconductor, data-center and space/defense equipment. Fluid & Metering Technologies sells pumps, meters and water-related products to industrial, chemical, energy and water customers. Fire & Safety/Diversified Products sells fire pumps, rescue tools (such as Hurst Jaws of Life) and dispensing equipment. Quarterly sales are roughly $0.9 billion. Much of this comes from replacement parts and consumables that customers buy again and again.
What usually moves IEX
- Industrial activity and customer capital spending
- Semiconductor, data-center and life-science equipment demand
- Order growth and backlog trends
- Acquisitions and margin improvement efforts
- US dollar exchange rates